Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + remifentanil conscious vs deep sedation for gastroscopy in obese patients
ChiCTR2500111635Phase 4Recruiting
- Sponsor
- Zigong Fourth People's Hospital
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and remifentanil in anxiety disorder (2 arms), sponsored by Zigong Fourth People's Hospital. Primary endpoints: Incidence of SpO2 < 95% and Incidence of SpO2 < 90%. Started Nov 2025; status: recruiting.
02
Drugs
remimazolamremifentanil
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2500111635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111635.